Home > Boards > US OTC > Medical - Equipment > StatSure Diagnostic Systems (SSUR)

FDA Approves CLIA Waiver for StatSure’s Patented Barrel

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Ubertino Member Profile
 
Followed By 102
Posts 27,030
Boards Moderated 4
Alias Born 02/01/04
160x600 placeholder
Ubertino   Tuesday, 11/06/07 09:31:03 AM
Re: None
Post # of 145 
FDA Approves CLIA Waiver for StatSure’s Patented Barrel Technology for Rapid HIV Testing

November 6, 2007
A valuation increase strengthens “BUY” ranking - We are increasing our modeled SSUR.OB’s valuation to $1.66

SSUR.OB’s stock price of $0.40 and market capitalization of $15.27 m is low when compared with its near and long-term potential and we are recommending a “BUY” with a valuation of $1.66.


http://www.scimitarequity.com/research/SSUR.OB_Mid-Quarter_Review.pdf




The SEC Must Go!
And jail shorters.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences